PUBLISHER: Lucintel | PRODUCT CODE: 1263946
PUBLISHER: Lucintel | PRODUCT CODE: 1263946
Glycomics/Glycobiology Market Trends and Forecast
The future of the glycomics/glycobiology market looks promising with opportunities in drug discovery & development and disease diagnostics. The global glycomics/glycobiology market is expected to reach an estimated $3.6 billion by 2028 with a CAGR of 14.8% from 2023 to 2028. The major drivers for this market are increasing research and development activities related to drug discovery along with rising investment by governments and organizations for academic research for development of new glycomics and glycobiology tools.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Glycomics/Glycobiology Market by Segment
Glycomics/Glycobiology Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
Glycosidases & Neuramidases
Glycosyltransferases & Sialyltransferases
Others
Mass Spectrometry Instruments
Chromatography Instruments
Arrays
Others
Oligosaccharides
Monosaccharides
Others
Glycomics/Glycobiology Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
Cancer Diagnostics
Others
Glycomics/GlycobiologyMarket by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
Glycomics/Glycobiology Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
List of Glycomics/Glycobiology Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, glycomics/glycobiology companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glycomics/glycobiology companies profiled in this report include-
Glycomics/Glycobiology Market Insights
Features of the Glycomics/Glycobiology Market
FAQ
Q1. What is the glycomics/glycobiology market size?
Answer: The global glycomics/glycobiology market is expected to reach an estimated $3.6 billion by 2028.
Q2. What is the growth forecast for glycomics/glycobiology market?
Answer: The global glycomics/glycobiology market is expected to grow with a CAGR of 14.8% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the glycomics/glycobiology market?
Answer: The major drivers for this market are increasing research and development activities related to drug discovery along with rising investment by governments and organizations for academic research for development of new glycomics and glycobiology tools.
Q4. What are the major segments for glycomics/glycobiology market?
Answer: The future of the glycomics/glycobiology market looks promising with opportunities in drug discovery & development and disease diagnostics.
Q5. Who are the key glycomics/glycobiology companies?
Answer: Some of the key glycomics/glycobiology companies are as follows:
Q6. Which glycomics/glycobiology segment will be the largest in future?
Answer:Lucintel forecasts that drug discovery and development will remain the largest segment over the forecast period due to the increasing research and development activities related to glycomics and proteomics.
Q7. In glycomics/glycobiology market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to increase in government fundings for research and development activities and presence of advanced healthcare infrastructure in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.